Jonathan Weissman

Jonathan Weissman, Ph.D., studies how cells ensure that proteins fold into their correct shape, as well as the role of protein misfolding in disease and normal physiology. He is also widely recognised for building innovative tools for broadly exploring organisational principles of biological systems. These include ribosome profiling, which globally monitors protein translation, CRISPRi/a for controlling the expression of human genes and rewiring the epigenome, and lineage tracing tools, to record the history of cells. Weissman is the Landon T. Clay Professor of Biology and a member of Whitehead Institute for Biomedical Research, a Professor of Biology Massachusetts Institute of Technology, a member of the Koch Institute for Integrative Cancer Research at MIT, and an Investigator at the Howard Hughes Medical Institute. He is a member of the National Academy of Sciences, a member of the Ludwig Center for Molecular Oncology, and a member of the European Molecular Biology Organization. Weissman also serves as a member on several Scientific Advisory Boards including Amgen, the Klarman Cell Observatory at Broad Institute, the Helen Hay Whitney Foundation, Stowers Institute for Biomedical Research, Tenaya Therapeutics, Tessera Therapeutics, and the Laboratory for Genomics Research. Additionally, he is the Head of SAB for the Innovative Genomics Institute. Weissman has received numerous awards including the Beverly and Raymond Sackler International Prize in Biophysics (2008), The Keith Porter Award Lecture from the American Society of Cell Biology (2015), the National Academy Science Award for Scientific Discovery (2015), and the Ira Herskowitz Award from the Genetic Society of America (2020).